Carlos Chiattone

Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma

Anas Younes, Laurie H. Sehn, Peter Johnson et al. · Journal of Clinical Oncology · 2019 · 591 citations · Full text

The outcome of peripheral T-cell lymphoma patients failing first-line therapy: a report from the prospective, International T-Cell Project

Monica Bellei, Francine M. Foss, Andrei R. Shustov et al. · Haematologica · 2018 · 149 citations · Full text

Simplified Geriatric Assessment in Older Patients With Diffuse Large B-Cell Lymphoma: The Prospective Elderly Project of the Fondazione Italiana Linfomi

Francesco Merli, Stefano Luminari, Alessandra Tucci et al. · Journal of Clinical Oncology · 2021 · 149 citations · Full text

Aging, Prognosis, Pathology +18

Improving acute promyelocytic leukemia (APL) outcome in developing countries through networking, results of the International Consortium on APL

Eduardo Magalhães Rego, Haesook T. Kim, Guillermo J. Ruíz‐Argüelles et al. · Blood · 2013 · 148 citations · Full text

Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma

Owen A. O’Connor, Muhıt Özcan, Eric D. Jacobsen et al. · Journal of Clinical Oncology · 2019 · 143 citations · Full text